We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Cryoelectron Microscopy Reveals the Ultrastructure of Retroviral Integrase-DNA Complexes

By LabMedica International staff writers
Posted on 29 Feb 2016
Advanced imaging technology has revealed the ultrastructure of the retrovirus intasome, the protein complex that controls the insertion of viral DNA into the host target cell.

The integrase enzyme catalyses the integration of viral DNA into host target DNA, which is an essential step in the life cycle of all retroviruses. More...
Previous structural characterization of integrase-viral DNA complexes, or intasomes, from the nonpathogenic prototype foamy virus (PFV) revealed a functional integrase tetramer, and it is generally believed that intasomes derived from other retroviral genera use tetrameric integrase. However, the intasomes of orthoretroviruses, which include all known pathogenic species, have not been characterized structurally.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) and Harvard Medical School (Boston, MA, USA) employed the advanced imaging technique cryoelectron microscopy (cryo-EM) to perform structural analysis studies on the pathogenic betaretrovirus, mouse mammary tumor virus (MMTV).

Researchers have historically relied on NMR and X-ray diffraction techniques to determine the structures of molecular complexes and proteins that play a role in the causes of various disease states. Structural information about a variety of medically important proteins and drugs has been obtained by these methods. Cryo-EM is a complementary analytical technique that provides near-atomic resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques. Cryo-EM allows the observation of specimens that have not been stained or fixed in any way, showing them in their native environment while integrating multiple images to form a three-dimensional model of the sample.

Results published in the February 17, 2016, online edition of the journal Nature revealed unexpected octameric integrase architecture for the MMTV. The structure was composed of two core integrase dimers, which interacted with the viral DNA ends and structurally mimicked the PFV integrase tetramer, and two flanking integrase dimers that engaged the core structure via their integrase carboxy-terminal domains. Contrary to the belief that tetrameric integrase components were sufficient to catalyze DNA insertion, the flanking integrase dimers were necessary for MMTV integrase activity.

"The details of how retroviruses integrate differ far more than previously thought and lead to entirely distinct patterns of infection," said contributing author Dr. Dmitry Lyumkis, a research fellow at the Salk Institute for Biological Studies.

"The MMTV intasome structure defines an unexpected novel paradigm for the structural basis of retroviral DNA integration," said senior author Dr. Alan Engelman, professor of medicine at Harvard Medical School.

Related Links:

Salk Institute for Biological Studies
Harvard Medical School



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.